<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "journalpublishing3.dtd">
<article xml:lang="en" article-type="retraction" xmlns:xlink="http://www.w3.org/1999/xlink">
<?release-delay 0|0?>
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">OL</journal-id>
<journal-title-group>
<journal-title>Oncology Letters</journal-title>
</journal-title-group>
<issn pub-type="ppub">1792-1074</issn>
<issn pub-type="epub">1792-1082</issn>
<publisher>
<publisher-name>D.A. Spandidos</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3892/ol.2021.12873</article-id>
<article-id pub-id-type="publisher-id">OL-0-0-12873</article-id>
<article-categories>
<subj-group>
<subject>Retraction</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>miR-154 inhibits migration and invasion of human non-small cell lung cancer by targeting ZEB2</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author"><name><surname>Lin</surname><given-names>Xingyu</given-names></name></contrib>
<contrib contrib-type="author"><name><surname>Yang</surname><given-names>Zhiguang</given-names></name></contrib>
<contrib contrib-type="author"><name><surname>Zhang</surname><given-names>Peng</given-names></name></contrib>
<contrib contrib-type="author"><name><surname>Liu</surname><given-names>Yunpeng</given-names></name></contrib>
<contrib contrib-type="author"><name><surname>Shao</surname><given-names>Guoguang</given-names></name></contrib>
</contrib-group>
<pub-date pub-type="ppub">
<month>08</month>
<year>2021</year></pub-date>
<pub-date pub-type="epub">
<day>18</day>
<month>06</month>
<year>2021</year></pub-date>
<volume>22</volume>
<issue>2</issue>
<elocation-id>612</elocation-id>
<permissions>
<copyright-statement>Copyright: &#x00A9; Lin et al.</copyright-statement>
<copyright-year>2021</copyright-year>
<license license-type="open-access">
<license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, reproduction and adaptation in any medium and for any purpose provided that it is properly attributed. For attribution, the original author(s), title, publication source (PeerJ) and either DOI or URL of the article must be cited.</license-p></license>
</permissions>
</article-meta>
</front>
<body>
<p>Oncol Lett 12: <related-article xmlns:xlink="http://www.w3.org/1999/xlink" related-article-type="retracted-article" vol="12" page="301" id="RA1" xlink:href="10.3892/ol.2016.4577" ext-link-type="doi">301-306</related-article>, 2016; DOI: 10.3892/ol.2016.4577</p>
<p>Following the publication of this paper, it was drawn to the Editors&#x0027; attention by a concerned reader that certain of the western blotting data shown in Figs. 3B, 4B and 5B bore unexpected similarities to data appearing in different form in other articles by different authors. Owing to the fact that some of the contentious data in the above article had already been published elsewhere, or were already under consideration for publication, prior to its submission to <italic>Oncology Letters</italic>, the Editor has decided that this paper should be retracted from the Journal. After having been in contact with the authors, they agreed with the decision to retract the paper. The Editor apologizes to the readership for any inconvenience caused.</p>
</body>
</article>
